Reporting of suspected adverse reactions
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Patients and healthcare professionals are asked to report all suspected adverse reactions via the national reporting system.

Belgium:
Federal agency for medicines and health products
Pharmacovigilance
Avenue Galilée 5/03, B-1210 Brussels
or
PO Box 97, B-1000 Brussels Madou
Website: www.notifieruneffetindesirable.be
e-mail: adr@fagg.be

Grand Duchy of Luxembourg:
Centre Régional de Pharmacovigilance de Nancy - Bâtiment de Biologie Moléculaire et de Biopathologie (BBB)
CHRU de Nancy – Hôpitaux de Brabois
Rue du Morvan – F-54 511 Vandœuvre-lès-Nancy Cedex
Tél  : (+33) 3 83 65 60 85 / 87
E-mail : crpv@chru-nancy.fr
ou
Direction de la Santé - Division de la Pharmacie et des Médicaments
20, rue de Bitbourg, L-1273 Luxembourg-Hamm
Tél. : (+352) 2478 5592
E-mail : pharmacovigilance@ms.etat.lu
Link for the form: https://guichet.public.lu/fr/entreprises/sectoriel/sante/medecins/notification-effets-indesirables-medicaments.html